Cardiovascular α1-adrenoceptor subtypes: Functions and signaling

Canadian Journal of Physiology and Pharmacology

Volumn 78, Issue 4, 2000, Pages 267-292

  Varma, Daya R ^a   Deng, Xing Fei ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Arrythmias; Cardiac hypertrophy; Central 1 adrenoreceptors; Inotropic responses

Indexed keywords

1 (4 AMINO 6,7 DIMETHOXY 2 QUINAZOLINYL) 4 (BICYCLO[2.2.2]OCTA 2,5 DIEN 2 YLCARBONYL)PIPERAZINE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 2 [[2 (4 HYDROXY 3 IODOPHENYL)ETHYL]AMINOMETHYL]TETRALONE; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CIRAZOLINE; CYCLAZOCINE; INOSITOL PHOSPHATE; METHOXAMINE; N [5 (4,5 DIHYDRO 1H IMIDAZOL 2 YL) 5,6,7,8 TETRAHYDRO 2 HYDROXY 1 NAPHTHYL]METHANESULFONAMIDE; NIGULDIPINE; NORADRENALIN; PHENOXYBENZAMINE; PHENTOLAMINE; PHENYLEPHRINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PRAZOSIN; PROTEIN KINASE C; RECEPTOR SUBTYPE; SILODOSIN;

CALCIUM CELL LEVEL; CHRONOTROPISM; HEART ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; VASOCONSTRICTION; ANIMAL; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; DRUG EFFECT; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; HUMANS; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0033624872     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y99-142     Document Type: Review

References (377)

1. 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Br. J. Pharmacol. 109: 80-87.
2. Ahlquist, R.P. 1948. A study of the adrenotropic receptors. Am. J. Physiol. 153: 586-600.
3. 1B-adrenergic receptors. J. Biol. Chem. 272: 21 253-21 259.
4. 1B-adrenergic receptor enhances mitogenesis and tumorigenecity. Proc. Natl. Acad. Sci. U.S.A. 88: 11 354-11 358.
5. Allo, S.N., Carl, L.L., and Morgan, H.E. 1992. Acceleration of growth of cultured cardiomyocytes and translocation of protein kinase C. Am. J. Physiol. 263: C319-C325.
6. 1-adrenergic receptors: the role of different second messenger pathways. J. Mol. Cell. Cardiol. 26: 391-402.
7. Anden, N.E., Gomes, C., Persson, B., and Trolin, G. 1978. R 28935 and prazosin: effects on central and peripheral alpha-adrenoceptor activity and on blood pressure. Naunyn-Schmiedebergs Arch. Pharmacol. 302: 299-306.
8. Anderson, K.E., and Woodcock, E.A. 1995. Preconditioning of perfused rat heart inhibits reperfusion-induced release of inositol(1,4,5)trisphosphate. J. Mol. Cell. Cardiol. 27: 2421-2431.
9. 1-adrenergic stimulation of normal and "ischemic" Purkinje fibers have different receptor-effector coupling mechanisms. Circ. Res. 71: 526-534.
10. + currents in rat ventricular myocytes. Proc. Natl. Acad. Sci. U.S.A. 85: 8756-8760.
11. 1-adrenergic receptor signaling in cardiac cells. EMBO J. 12: 5131-5139.
12. Arreola, J., Dirksen, R.T., Perez-Cornejo, P., Piech, K.M.M. and Sheu, S.S. 1994. Autonomic modulation of action potential and tension in guinea pig papillary muscles. Eur. J. Pharmacol. 271: 309-317.
13. 1-adrenoceptor to a phospholipase C. J. Biol. Chem. 268: 27 390-27 397.
14. 1-adrenergic mechanism. Circ. Res. 73: 656-670.
15. Barinaga, M. 1998. Signaling path may lead to better heart-failure therapies. Science (Washington, D.C.), 280: 383.
16. 1B-adrenergic receptor mRNAs in the hearts of cardiomyopathic hamsters. J. Mol. Cell. Cardiol. 29: 111-119.
17. Benfey, B.G. 1971. Lack of relationship between myocardial cyclic AMP concentrations and inotropic effects of sympathomimetic amines. Br. J. Pharmacol. 43: 757-763.
18. 1-adrenoceptor blocking drugs in experimental coronary artery occlusion and reperfusion. Can. J. Physiol. Pharmacol. 71: 103-111.
19. Benfey, B.G., and Varma, D.R. 1967. Interactions of sympathomimetic drugs, propranolol and phentolamine, on atrial refractory period and contractility. Br. J. Pharmacol. 30: 603-611.
20. Benfey, B.G., Elfellah, M.S., Ogilvie, R.I., and Varma, D.R. 1984. Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs. Br. J. Pharmacol. 82: 717-725.
21. Bevan, J.A. 1981. A comparison of the contractile responses of the rabbit basilar and pulmonary arteries to sympathomimetic agonists: further evidence for variation in vascular adrenoceptor characteristics. J. Pharmacol. Exp. Ther. 216: 83-89.
22. Bevan, R.D. 1975. Effect of sympathetic denervation on smooth muscle cell proliferation in the growing rabbit ear artery. Circ. Res. 37: 14-19.
23. Bishopric, N.H., and Kedes, L. 1991. Adrenergic regulation of the skeletal α-actin gene promoter during myocardial cell hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 88: 2132-2136.
24. 1-adrenoceptor-mediated hypertrophy of rat cardiac myocytes. J. Clin. Invest. 80: 1194-1199.
25. Blaes, N., and Boissel, J.P. 1983. Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J. Cell. Physiol. 116: 167-172.
26. Bognar, I.T., Baretti, R., Fischer, S., Veldet, C., and Fuder, H. 1990. Alpha-adrenoceptor mediated facilitation of acetylcholine release in the perfused rat heart. J. Pharmacol. Exp. Ther. 254: 702-710.
27. Bogoyevitch, M.A., and Sugden, P.H. 1996. The role of protein kinases in adaptational growth of the heart. Int. J. Biochem. Cell Biol. 28: 1-12.
28. Bogoyevitch, M.A., Parker, P.J., and Sugden, P.H. 1993. Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-epsilon is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin. Circ. Res. 72: 757-767.
29. Bogoyevitch, M.A., Marshall, C.J., and Sugden, P.H. 1995. Hypertrophic agonists stimulate the activities of the protein kinases c-Raf and A-Raf in cultured ventricular myocytes. J. Biol. Chem. 270: 26 303-26 310.
30. Bogoyevitch, M.A., Andersson, M.B., Gillespie-Brown, J., Clerk, A., Glennon, P.E., Fuller, S.J., and Sugden, P.H. 1996. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem. J. 314: 115-121.
31. 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes: evidence for involvement of p70s6 kinase. Circ. Res. 81: 176-186.
32. 1-Adrenoceptor regulation of delayed afterdepolarizations and triggered activity in sub-endocardial Purkinje fibers surviving 1 day of myocardial infarction. J. Mol. Cell. Cardiol. 23: 83-90.
33. 1-and β-Adrenergic interactions on L-type calcium current in cardiac myocytes. Pflugers Arch. Eur. J. Physiol. 421: 397-399.
34. 1-adrenergic regulation of the transient outward current in rabbit atrial myocytes. J. Physiol. (London), 431: 689-712.
35. Bristow, M.R., Ginsburg, R., Minobe, W., Cubicciotti, R.S., Sageman, W.S., Lurie, K., Billingham, M.E., Harrison, D.C., and Stinson, E.B. 1982. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N. Engl. J. Med. 307: 205-211.
36. Brodde, O.E. 1990. β- and α-Adrenoceptor-agonists and -antagonists in chronic heart failure. Basic Res. Cardiol. 85(Suppl. 1): 57-66.
37. Brodde, O.E., Michel, M.C., and Zerkowski, H.R. 1995. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc. Res. 30: 570-584.
38. Bruckner, R., Meyer, W., Mugge, A., Schmitz, W., and Scholz, H. 1984. α-Adrenoceptor-mediated positive inotropic effect of phenylephrine in isolated human ventricular myocardium. Eur. J. Pharmacol. 99: 345-347.
39. 1D subtype. Eur. J. Pharmacol. 297: 241-248.
40. Buxton, I.L., and Brunton, L.L. 1986. α-Adrenergic receptors on rat ventricular myocytes: characteristics and linkage to cAMP metabolism. Am. J. Physiol. 251: H307-H313.
41. 2+ homeostasis of cardiac myocytes. Circ. Res. 69: 540-550.
42. 1b-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 94: 11 589-11 594.
43. 1-adrenoreceptor subtypes in vitro and in situ. J. Biol. Chem. 270: 30 980-30 988.
44. 2+ currents in cardiac ventricular myocytes. Circ. Res. 79: 184-193.
45. h is subtype specific and independent of its transglutaminase activity. J. Biol. Chem. 271: 32 385-32 391.
46. Chevalier, P., Ruffy, F., Danilo, P., and Rosen, M.R. 1998. Interaction between alpha-1 adrenergic and vagal effects on cardiac rate and repolarization. J. Pharmacol. Exp. Ther. 284: 832-837.
47. Chien, K.R., Knowlton, K.U., Zhu, H., and Chien, S. 1991. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 5: 3037-3046.
48. Chung, J., Grammer, T.C., Lemon, K.P., Kazlauskas, A., and Blenis, J. 1994. PDGF-and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature (London), 370: 71-75.
49. Clerk, A., Bogoyevitch, M.A., Anderson, M.B., and Sugden, P.H. 1994. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J. Biol. Chem. 269: 32 848-32 857.
50. Corr, P.B., Yamada, K.A., and DaTorre, S.D. 1990. Modulation of α-adrenergic receptor and their intracellular coupling in the ischemic heart. Basic Res. Cardiol. 85(Supp 1): 31-45.
51. 1-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 85: 7159-7163.
52. Culling, W., Penny, W.J., Cunliffe, G., Flores, N.A., and Sheridan, D.J. 1987. Arrhythmogenic and electrophysiological effects of α-adrenoceptor stimulation during myocardial ischaemia and reperfusion. J. Mol. Cell. Cardiol. 19: 251-258.
53. Dale, H.H. (1906). On some physiological actions of ergot. J. Physiol. (London), 34: 1-35.
54. Decker, R.S., Cook, M.G., Behnke-Barclay, M.M., Decker, M.L., Lesch, M., and Samarel, A.M. 1993. Catecholamines modulate protein turnover in cultured, quiescent rabbit cardiac myocytes. Circ. Res. 265: H329-H339.
55. 1-adrenergic receptor subtypes modulate catecholamine-induced increases and decreases in ventricular automaticity. Circ. Res. 67: 1535-1551.
56. 1D-Adrenoceptors do not contribute to inotropic responses of neonatal rat myocardium. J. Cardiovasc. Pharmacol. 29: 57-60.
57. Deng, X.F., Chemtob, S., Almazan, G., and Varma, D.R. 1996a. Ontogenic differences in the functions of myocardial alpha-1 adrenoceptor subtypes in rats. J. Pharmacol. Exp. Ther. 276: 1155-1161.
58. 1D-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br. J. Pharmacol. 119: 269-276.
59. 1-adrenoceptor-mediated inotropic responses of neonatal rat hearts. Am. J. Physiol. 273: H113-H1118.
60. Deng, X.F., Sculptoreanu, A., Mulay, S., Peri, K.G., Li, J.F., Zheng, W.H., Cheemtob, S., and Varma, D.R. 1998. Crosstalk between alpha-1A and alpha-1B adrenoceptors in neonatal rat myocardium: implications in cardiac hypertrophy. J. Pharmacol. Exp. Ther. 286: 489-496.
61. 1-adrenoceptors and protein kinase C. Am. J. Physiol. 258: H907-H911.
62. Disatnik, M.H., Jones, S.N., and Mochly-Rosen, D. 1995. Stimulus-dependent subcellular localization of activated protein kinase C; a study with acidic fibroblast growth factor and transforming growth factor-beta 1 in cardiac myocytes. J. Mol. Cell. Cardiol. 27: 2473-2481.
63. Divecha, N., and Irvine, R.F. 1995. Phospholipid signaling. Cell, 80: 269-278.
64. 2-adrenoceptors. Eur. J. Pharmacol. 361: 1-15.
65. Du, X.J., Anderson, K.E., Jacobsen, A., Woodcock, E.A., and Dart, A.M. 1995. Suppression of ventricular arrhythmias during ischemia-reperfusion by agents inhibiting Ins(1,4,5)P3 release. Circulation, 91: 2712-2716.
66. Dunnmon, P.M., Iwaki, K., Henderson, S.A., Sen, A., and Chien, K.R. 1990. Phorbol esters induce immediate-early genes and activate gene transcription in neonatal rat myocardial cells. J. Mol. Cell. Cardiol. 22: 901-910.
67. 2+ mediated through α-and β-adrenoceptors. Circ. Res. 62: 247-265.
68. Endoh, K., Satoh, K., and Taira, N. 1982. α-Adrenoceptors mediating the positive inotropic effect of phenylephrine in the right ventricular muscle of the monkey (Macaca fuscata). Naunyn-Schmiedebergs Arch. Pharmacol. 318: 370-373.
69. 1-adrenoceptor-mediated positive inotropic effect in the rabbit ventricular myocardium. Brit. J. Clin. Pharmacol. 30(Suppl. 1): 115S-117S.
70. 1-adrenoceptors mediate positive inotropic effect and changes in phosphatidylinositol metabolism. Species differences in receptor distribution and the intracellular coupling process in mammalian ventricular myocardium. Circ. Res. 68: 1179-1190.
71. 1A - subtype antagonists WB 4101 and 5-methylurapidil. Naunyn-Schmiedebergs Arch. Pharmacol. 345: 578-585.
72. 1-adrenoceptor-mediated positive inotropic effect. Am. J. Physiol. 260: H27-H36.
73. 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. Mol. Pharmacol. 47: 977-985.
74. Eskildsen-Helmond, Y.E., Van Heugten, H.A., and Lamers, J.M. 1996. Regulation and functional significance of phospholipase D in myocardium. Mol. Cell. Biochem. 157: 39-48.
75. Exton, J.H. 1994. Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta, 1212: 26-42.
76. Fabiato, A., and Fabiato, F. 1978. Effect of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiac and skeletal muscles. J. Physiol. (London), 276: 233-255.
77. 1-adrenoceptor stimulation in rat cardiac myocytes. Circ. Res. 71: 673-688.
78. 1-Adrenoceptors in myocardium: functional aspect and transmembrane signaling mechanisms. Physiol. Rev. 73: 469-487.
79. Fitzgerald, M., Anderson, K.E., and Woodcock, E.A. 1994. Inositol 1,4,5-trisphosphate receptor function in neonatal cardiomyocytes. Eur. J. Pharmacol. 268: 275-278.
80. 1-Adrenoceptors can mediate chronotropic responses in the rat heart. Br. J. Pharmacol. 73: 586-588.
81. 1-Adreenoceptor sub-classification in vascular smooth muscle. Trends Pharmacol. Sci. 7: 347-349.
82. + exchanger in the mammalian myocardium. J. Mol. Cell. Cardiol. 29: 1991-1999.
83. 1B-adrenergic receptor subcellular distribution and function. J. Biol. Chem. 270: 8902-8909.
84. 1-Adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol. Sci. 15: 167-170.
85. Fronek, K. 1983. Trophic effect of the sympathetic nervous system on vascular smooth muscle. Ann. Biomed. Eng. 11: 607-615.
86. Fu, L.X., Feng, Q.P., Liang, Q.M., Sun, X.Y., Hedner, T., Hoebeke, J., and Hjalmarson, A. 1993. Hypersensitivity of Gi protein mediated muscarinic receptor adenylyl cyclase in chronic ischemic heart failure in the rat. Cardiovasc. Res. 27: 2065-2070.
87. 1-adrenergic stimulation in rat embryos. Dev. Biol. 162: 558-567.
88. 1-adrenoceptor subtypes at the beginning of neurulation in rat embryos. Toxicol. in Vitro, 9: 601-606.
89. Fuller, S.J., Gaitanaki, C.J., and Sugden, P.H. 1989. Effects of increasing extracellular pH on protein synthesis and protein degradation in the perfused working rat heart. Biochem. J. 259: 173-179.
90. 1-adrenergic stimulation of cardiac protein synthesis may involve increased intracellular pH and protein kinase activity. Biochem. J. 273: 347-353.
91. 2+ in cardiac myocytes. Circ. Res. 71: 870-882.
92. 2+ and pH homeostasis in rat cardiac myocytes. Am. J. Physiol. 274: H1152-H1162.
93. 1B adrenergic receptor gene in liver is controlled by three promoters. J. Biol. Chem. 269: 15 762-15 767.
94. Geller, J.C., Cua, M., Prieto, L., Guo, S.D., Danilo, P., and Rosen, M.R. 1995. Chloroethylclonidine increases the incidence of lethal arrhythmias during coronary occlusion in anesthetized dogs. Eur. J. Pharmacol. 294: 423-428.
95. 1B-adrenoceptor antagonist. Eur. J. Pharmacol. 287: 13-16.
96. Glennon, P.E., Sugden, P.H., and Poole-Wilson, P.A. 1995. Cellular mechanisms of cardiac hypertrophy. Brit. Heart J. 73: 496-499.
97. Glennon, P.E., Kaddoura, S., Sale, E.M., Sale, G.J., Fuller, S.J., and Sugden, P.H. 1996. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach down-regulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ. Res. 78: 954-961.
98. 1-adrenoceptors. Eur. J. Pharmacol. 272: R5-6.
99. Goldman, W.F., and Saum, W.R. 1984. A direct excitatory action of catecholamines on rat aortic baroreceptors in vitro. Circ. Res. 55: 18-30.
100. Gould, D.J., Vidovic, M., and Hill, C.E. 1995. Cross talk between receptors mediating contractions and relaxation in the arterioles but not the dilator muscles of the rat iris. Br. J. Pharmacol. 115: 828-834.
101. Govier, W.C. 1967. A positive inotropic effect of phenylephrine mediated by alpha adrenergic receptors. Life Sci. 6: 1361-1365.
102. Govier, W.C., Mosal, N.C., Whittington, P., and Broom, A.H. 1966. Myocardial alpha and beta adrenergic receptors as demonstrated by atrial functional refractory-period changes. J. Pharmacol. Exp. Ther. 154: 255-263.
103. 1-adrenergic receptor and identification of the hormone binding subunit. J. Biol. Chem. 257: 15 174-15 181.
104. 1-Adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ. Res. 78: 737-749.
105. Gross, G., and Lues, I. 1985. Thyroid-dependent alterations of myocardial receptors and adrenoceptor-mediated responses in the rat. Naunyn-Schmiedebergs Arch. Pharmacol. 329: 427-439.
106. 1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy. Am. J. Physiol. 275: H1338-H1350.
107. Haeusler, G. 1973. Activation of central pathway of the baro-receptor reflex, a possible mechanism of the hypotensive action of clonidine. Naunyn-Schmiedebergs Arch. Pharmacol. 231: 231-246.
108. Haft, J.I. 1974. Cardiovascular injury induced by sympathetic catecholamines. Prog. Cardiovasc. Dis. 17: 73-86.
109. Hajjar, R.J., Muller, F.U., Schmitz, W., Schnabel, P., and Bohm, M. 1998. Molecular aspects of adrenergic signal transduction in cardiac failure. J. Mol. Med. 76: 747-755.
110. Hamra, M., and Rosen, M.R. 1988. α-Adrenergic receptor stimulation during simulated ischemia and reperfusion in canine cardiac Purkinje fibers. Circulation, 78: 1495-1502.
111. 1-adrenergic receptors revealed by chlorethylclonidine. Mol. Pharmacol. 32: 505-510.
112. 2+ in smooth muscle. Nature (London), 329: 333-335.
113. 1-adrenergic receptor complex. Circ. Res. 65: 1763-1773.
114. Handa, Y., Wagner, J., Inui, J., Averesch, H., and Schumann, H. 1982. Effect of α-and β-sympathomimetic agonists on calcium-dependent slow action potential and force of contraction in the rabbit papillary muscle. Naunyn-Schmiedebergs Arch. Pharmacol. 318: 330-335.
115. 2+ signaling in quiescent neonatal cardiac myocytes. Biochim. Biophys. Acta, 1224: 517-526.
116. Hartmann, H.A., Mazzocca, N.J., Kleiman, R.B., and Houser, S.R. 1988. Effects of phenylephrine on calcium current and contractility of feline ventricular myocytes. Am. J. Physiol. 255: H1173-H1180.
117. Head, R.J. 1991. Hypernoradrenergic innervation and vascular smooth muscle hyperplastic changes. Blood Vessels, 28: 173-178.
118. 1-adrenergic stimulation in adult cardiac myocytes. Biochim. Biophys. Res. Commun. 156: 485-492.
119. 1-adrenergic stimulation in cardiac myocytes exposed to hypoxia. J. Clin. Invest. 83: 1409-1413.
120. Helin, P., Lorenzen, I., Garbarsch, C., and Matthiessen, M.E. 1970. Atherosclerosis in rabbit aorta induced by noradrenaline. Atherosclerosis, 12: 125-133.
121. Hescheler, J., Nawrath, H., Tang, M., and Trautwein, W. 1988. Adrenoceptor-mediated changes in excitation and contraction in ventricular heart muscle from guinea-pigs and rabbits. J. Physiol. (London), 397: 657-670.
122. 1-Adrenergic mechanisms in myocardial ischemia. Circulation, 81: 1-13.
123. Hewett, K.W., and Rosen, M.R. 1985. Developmental changes in the rabbit sinus node action potential and its response to adrenergic agonists. J. Pharmacol. Exp. Ther. 235: 308-312.
124. Heylinger, C.E., Pierce, G.N., Singal, P.K., Beamish, R.E., and Dhalla, N.S. 1982. Cardiac α-and β-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res. Cardiol. 77: 610-618.
125. 1-adrenoceptors: consensus update. Pharmacol. Rev. 47: 267-270.
126. 1-adrenoceptors irrespective of the subtype. Mol. Pharmacol. 52: 764-770.
127. 1-adrenergic inhibition of the β-adrenergically activated chloride current in cardiac myocytes. Mol. Pharmacol. 51: 853-860.
128. 1-adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. J. Pharmacol. Exp. Ther. 290: 452-463.
129. 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation, 92: 2259-2265.
130. 1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase. J. Pharmacol. Exp. Ther. 290: 28-37.
131. 2-adrenoceptors in the modulation of the baroreflex vagal bradycardia. Eur. J. Pharmacol. 71: 455-461.
132. 3H]INS(1,4,5)P3 binding site in rat heart sarcoplasmic reticulum. J. Mol. Cell. Cardiol. 26: 341-349.
133. 1-adrenergic receptor agonist binding and activation. J. Biol. Chem. 271: 6322-6327.
134. 1-adrenergic receptor subtype selective agonist binding. J. Biol. Chem. 270: 23 189-23 195.
135. 1-Adrenergic receptor coupling with Gh in the failing human heart. Circulation, 94: 718-726.
136. 1-Adrenergic stimulation is coupled to cardiac myocyte hypertrophy. Am. J. Physiol. 260: H953-H956.
137. 1-adrenergic receptor. J. Biol. Chem. 265: 18 952-18 960.
138. Inayatulla, A., Li, D.Y, Chemtob, S., and Varma, D.R. 1994. Ontogeny of positive inotropic responses to sympathomimetic agents and of myocardial adrenoceptors in rats. Can. J. Physiol. Pharmacol. 72: 361-367.
139. Ishac, E.J.N., Pennefather, J.N., and Handberg, G.M. 1983. Effect of changes in thyroid state on atrial α-and β-adrenoceptors, adenylate cyclase activity, and catecholamine levels in the rat. J. Cardiovasc. Pharmacol. 5: 396-404.
140. Iwaki, K., Sukhatme, V.P., Shubeita, H.E., and Chien, K.R. 1990. α-and β-Adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. J. Biol. Chem. 265: 13 809-13 817.
141. Izumo, S., and Aoki, H. 1998. Calcineurin - the missing link in cardiac hypertrophy. Nature Med. 4: 661-662.
142. Jackson, C.L., and Schwartz, S.M. 1992. Pharmacology of smooth muscle cell replication. Hypertension, 20: 713-736.
143. Jefferies, H.B., Reinhard, C., Kozma, S.C., and Thomas, G. 1994. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc. Natl. Acad. Sci. U.S.A. 91: 4441-4445.
144. Johnson, J.A., and Mochly-Rosen, D. 1995. Inhibition of the spontaneous rate of contraction of neonatal cardiac myocytes by protein kinase C isozymes. A putative role for the epsilon isozyme. Circ. Res. 76: 654-663.
145. 1-adrenergic activity in cardiomyopathic Syrian hamster. Am. J. Physiol. 260: H80-H88.
146. 1-Adrenoceptor mediated signal transduction in neonatal rat ventricular myocytes. Effects of prolonged hypoxia and re-oxygenation. Cardiovasc. Res. 25: 609-616.
147. Kariya, K., Karns, L.R., and Simpson, P.C. 1991. Expression of a constitutively activated mutant of the β-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the beta-myosin heavy chain isogene. J. Biol. Chem. 266: 10 023-10 026.
148. 1-adrenergic-and β-protein kinase C-inducible element in the rat β-myosin heavy chain promoter. J. Biol. Chem. 268: 26 658 - 26 662.
149. 1-adrenergic agonist and activated β-protein kinase C in hypertrophy of cardiac myocytes. J. Biol. Chem. 269: 3775-3782.
150. 3H)-prazosin. Biochim. Biophys. Res. Commun. 90: 142-149.
151. 1-agonist-mediated phosphatidylinositide turnover and myocardial cell hypertrophy in neonatal rat ventricular myocytes. Experientia, 46: 81-84.
152. Karmazyn, M., and Haist, J.V. 1993. Calcium dependent positive inotropic effects of low phorbol ester concentrations in isolated rat hearts. Cardiovasc. Res. 27: 390-395.
153. 1-adrenergic induction of the skeletal α-actin promoter during cardiac myocyte hypertrophy. J. Biol. Chem. 270: 410-417.
154. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol. 115: 981-986.
155. 3. Am. J. Physiol. 258: H610-H615.
156. Kijima, Y., and Fleischer, S. 1992. Two types of inositol trisphosphate binding in cardiac microsomes. Biochim. Biophys. Res. Commun. 189: 728-735.
157. Kijima, Y., Saito, A., Jetton, T.L., Magnuson, M.A., and Fleischer, S. 1993. Different intracellular localization of inositol 1,4,5-trisphosphate and ryanodine receptors in cardiomyocytes. J. Biol. Chem. 268: 3499-3506.
158. 1-adrenoceptor responsiveness and expression. Eur. J. Pharmacol. 208: 231-238.
159. 1-adrenoceptors which mediate chronotropy in neonatal rat cardiac myocytes. Comp. Biochem. Physiol. 105C: 479-485.
160. 1-adrenergic receptor agonist, selective for the α1A receptor subtype. J. Pharmacol. Exp. Ther. 274: 97-103.
161. Knowlton, K.U., Baracchini, E., Ross, R.S., Harris, A.N., Henderson, S.A., Evans, S.M., Glembotski, C.C., and Chien, K.R. 1991. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during α-adrenergic stimulation of neonatal rat ventricular cells. J. Biol. Chem. 266: 7759-7768.
162. 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J. Biol. Chem. 268: 15 374-15 380.
163. Knowlton, K.U., Rockman, H.A., Itani, M., Vovan, A., Seidman, C.E., and Chien, K.R. 1995. Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium. J. Clin. Invest. 96: 1311-1318.
164. Kobinger, W. 1978. Central α-adrenergic system as targets of hypotensive drugs. Rev. Physiol. Biochem. Pharmacol. 81: 39-100.
165. 1-adrenoceptor agonist. Eur. J. Pharmacol. 82: 203-206.
166. 1-adrenoceptor-mediated increase of inositol trisphosphate in the human heart. J. Cardiovasc. Pharmacol. 13: 324-327.
167. Kones, R.J. 1979. Emotional stress, plasma catecholamines, cardiac risk factors, and atherosclerosis. Angiology, 30: 327-336.
168. Kukreja, R.S., Datta, B.N., and Chakravarti, R.N. 1981. Catecholamine-induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis, 40: 291-298.
169. Kunos, G. 1977. Thyroid hormone-dependent interconversion of myocardial α-and β-adrenoceptors in the heart. Br. J. Pharmacol. 59: 177-189.
170. Kunos, G., and Nickerson, M. 1977. Effects of sympathetic innervation and temperature on the properties of rat heart adrenoceptors. Br. J. Pharmacol. 59: 603-614.
171. Kunos, G., Vermes-Kunos, I., and Nickerson, M. 1974. Effects of thyroid state on adrenoceptor properties. Nature (London), 250: 779-781.
172. Kunos, G., Mucci, L., and O'Regan, S. 1980. The influence of hormonal and neuronal factors on rat heart adrenoceptors. Br. J. Pharmacol. 71: 371-386.
173. 3H]phenoxybenzamine. J. Biol. Chem. 258: 326-332.
174. Kunze, D.L., Krauhs, J.M., and Orlea, C.J. 1984. Direct action of norepinephrine on aortic baroreceptors of rat adventitia. Am. J. Physiol. 247: H811-H816.
175. 1-Adrenergic system and arrhythmias in ischaemic heart disease. Eur. Heart J. 12(Suppl. F): 88-98.
176. Kushida, H., Hiramoto, T., Satoh, H., and Endoh, M. 1988. Phorbol ester does not mimic, but antagonizes the α-adrenoceptor-mediated positive inotropic effect in the rabbit papillary muscle. Naunyn-Schmiedebergs Arch. Pharmacol. 337: 169-176.
177. 1-adrenergic stimulation. J. Biol. Chem. 269: 13 490-13 496.
178. Langer, S.Z. 1981. Presynaptic Regulation of the Release of Catecholamines. Pharmacol. Rev. 32: 337-362.
179. 1A subtype. Mol. Pharmacol. 46: 414-422.
180. 2-adrenergic receptor mRNAs by thyroid state in the rat. Endocrinology (Baltimore), 129: 1116-1118.
181. Lazou, A., Bogoyevitch, M.A., Clerk, A., Fuller, S.J., Marshall, C.J., and Sugden, PH. 1994a. Regulation of mitogen-activated protein kinase cascade in adult rat heart preparations in vitro. Circ. Res. 75: 932-941.
182. 1-adrenergic agonists in adult rat hearts. Am. J. Physiol. 267: H970-H978.
183. 1-Adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells. J. Biol. Chem. 263: 7352-7358.
184. 1-adrenergic receptor. J. Biol. Chem. 259: 2579-2587.
185. max of isolated myocardial papillary muscles. Can. J. Physiol. Pharmacol. 69: 1804-1809.
186. 1-adrenoceptor: inotropic effect and physiologic and pathologic implications. Life Sci. 60: 1305-1318.
187. 1-adrenergic receptors. Circ. Res. 81: 396-403.
188. Limas, C., and Limas, C.J. 1987. Altered intracellular adrenoceptor distribution in myocardium of spontaneously hypertensive rats. Am. J. Physiol. 253: H904-H908.
189. Liu, Q.Y., Karpinski, E., and Pang, P.K. 1994. L-channel modulation by alpha-1 adrenoceptor activation in neonatal rat ventricular cells: intracellular mechanisms. J. Pharmacol. Exp. Ther. 271: 944-951.
190. Ljung, B., and Kjellstedt, A. 1987. Functional antagonism of noradrenaline responses by felodipine and other calcium antagonists in vascular smooth muscles. J. Cardiovasc. Pharmacol. 10(Suppl. 1): S82-88.
191. 1-adrenergic receptor: purification and characterization of the native receptor ligand binding subunit. J. Biol. Chem. 261: 7710-7716.
192. Lomasney, J.W., Cotecchia, S., Lefkowitz, R.J., and Caron, M.G. 1991a. Molecular biology of α-adrenergic receptors: implications for receptor classification and for structure-function relationship. Biochim. Biophys. Acta, 1095: 127-139.
193. 1A-adrenergic receptor: the gene for which is located on human chromosome 5. J. Biol. Chem. 266: 6365-6369.
194. 1-Adrenergic receptor stimulation of sarcomeric actin isogene transcription in hypertrophy of cultured rat heart muscle cells. J. Clin. Invest. 83: 1078-1082.
195. Long, C.S., Kariya, K., Karns, L., and Simpson, P.C. 1992. Sympathetic modulation of the cardiac myocyte phenotype: studies with a cell-culture model of myocardial hypertrophy. Basic Res. Cardiol. 87(Suppl. 2): 19-31.
196. 3 responses in cerebral arteries. Am. J. Physiol. 270: H915-H923.
197. Malfatto, G., Rosen, T.S., Steinberg, S.F., Ursell, P.C., Sun, L.S., Daniel, S., Danilo, P., and Rosen, M.R. 1990. Sympathetic neural modulation of cardiac impulse initiation and repolarization in the newborn rat. Circ. Res. 66: 427-437.
198. 1-adrenergic receptors in the intermediolateral column in mediating the pressor responses elicited by the stimulation of ventrolateral medullary pressor area. Brain Res. 626: 278-286.
199. Marks, A.R., Tempst, P., Chadwick, C.C., Riviere, L., Fleischer, S., and Nadal-Ginard, B. 1990. Smooth muscle and brain inositol 1,4,5-trisphosphate receptors are structurally and functionally similar. J. Biol. Chem. 265: 20 719-20 722.
200. 1-adrenergic receptor antagonists. J. Autonom. Nerv. Sys. 3: 9-23.
201. McGrath, J.C. 1982. Evidence for more than one type of post-junctional α-adrenoceptor. Biochem. Pharmacol. 31: 467-484.
202. 1-adrenergic receptor. Circ. Res. 60: 465-471.
203. 1-Adrenergic stimulation of rat myocardial cells increases protein synthesis. Am. J. Physiol. 251: H1076-H1084.
204. Melville, K.I. 1937. The antisympathomimetic actions of dioxane compounds (F883 and F933), with special reference to the vascular responses to dihydroxyphenyl ethanolamine (arterenol) and nerve stimulation. J. Pharmacol. Exp. Ther. 59: 317-327.
205. 1-adrenoceptors and protein synthesis. J. Mol. Cell. Cardiol. 28: 2017-2025.
206. 1-adrenoceptor subtypes in rat heart. Br. J. Pharmacol. 111: 533-538.
207. 1-adrenoceptor subtypes mediating inotropic effects in rat right ventricle. Br. J. Pharmacol. 111: 539-546.
208. Mignery, G.A., Newton, C.L., Archer, B.T., and Sudhof, T.C. 1990. Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 265: 12 679-12 685.
209. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 91: 10 109-10 113.
210. Mochly-Rosen, D., Khaner, H., Lopez, J., and Smith, B.L. 1991. Intracellular receptors for activated protein kinase C. Identification of a binding site for the enzyme. J. Biol. Chem. 266: 14 866-14 868.
211. 1-adrenoceptors in guinea-pig left atrium. Naunyn-Schmiedebergs Arch. Pharmacol. 336: 403-408.
212. 1-adrenergic receptor subtype is responsible for delayed afterdepolarizations and triggered activity during simulated ischemia and reperfusion of isolated canine Purkinje fibers. Circulation, 84: 1732-1740.
213. Molkentin, J.D., Lu, J.R., Antos, C.L., Markham, B., Richardson, J., Robbins, J., Grant, S.R., and Olson, E.N. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell, 93: 215-228.
214. Monfar, M., Lemon, K.P., Grammer, T.C., Cheatham, L., Chung, J., Vlahos, C.J., and Blenis, J. 1995. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol. Cell. Biol. 15: 326-337.
215. Moran, N.C., and Perkins, M.E. 1961. An evaluation of adrenergic blockade of the mammalian heart. J. Pharmacol. Exp. Ther. 133: 192-201.
216. Morano, I., Hofmann, F., Zimmer, M., and Ruegg, J.C. 1985. The influence of P-light chain phosphorylation by myosin light chain kinase on the calcium sensitivity of chemically skinned heart fibers. FEBS Lett. 189: 221-224.
217. Morgan, H.E., and Baker, K.M. 1991. Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation, 83: 13-25.
218. 1-adrenergic receptor mRNA levels. J. Biol. Chem. 266: 2233-2238.
219. 3H]prazosin binding. Mol. Pharmacol. 29: 321-330.
220. 1-adrenergic stimulation and reperfusion of ischaemic rat heart. J. Mol. Cell. Cardiol. 23: 841-850.
221. 2+ from permeabilized cardiac myocytes and sarcoplasmic reticulum. FEBS Lett. 185: 328-332.
222. Mukherjee, A., Haghani, Z., Brady, J., Bush, L., Mcbride, W., Buja, L.M., and Willerson, J.T. 1983. Differences in myocardial α-and β-adrenergic receptor numbers in different species. Am. J. Physiol. 245: H957-H961.
223. 1-Receptor localization in rat heart and kidney using autoradiography. Am. J. Physiol. 249: H512-H519.
224. 1-Adrenoceptor subtypes mediating inotropic and electrophysiological effects in mammalian myocardium. Am. J. Physiol. 271: H1423-H1432.
225. Nakanishi, T., Kamata, K., Nojima, K., Seguchi, M., and Takao, A. 1989. Inotropic effect of phenylephrine and myocardial α-adrenergic receptors in newborn and adult animals. J. Mol. Cell. Cardiol. 21: 975-985.
226. h: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science (Washington, D.C.), 264: 1593-1596.
227. Nakashima, M., Tsuru, H., and Shigei, T. 1973. Stimulant action of methoxamine in the isolated atria of normal and 6-propyl-2-thiouracil-fed rats. Jpn. J. Pharmacol. 23: 307-312.
228. Nawrath, H. 1989. Adrenoceptor-mediated changes of excitation and contraction in isolated heart muscle preparations. J. Cardiovasc. Pharmacol. 14(Suppl. 3): S1-10.
229. 1A-adrenergic receptor-stimulated prostaglandin synthesis. J. Pharmacol. Exp. Ther. 263: 987-996.
230. Nichols, A.J., and Ruffolo, R.R. 1991. Functions mediated by α-adrenoceptors. Prog. Basic Clin. Pharmacol. 8: 115-179.
231. Nickerson, M. 1949. The pharmacology of adrenergic blockade. Pharmacol. Rev. 1: 27-101.
232. Nickerson, M., and Chan, G.C.M. 1961. Blockade of responses of isolated myocardium to epinephrine. J. Pharmacol. Exp. Ther. 133: 186-191.
233. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Washington, D.C.), 258: 607-614.
234. Nishizuka, Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9: 484-496.
235. 1-adrenoceptor subtypes in rat heart: a binding study. Br. J. Pharmacol. 114: 1026-1030.
236. Northover, B.J. 1993. Phorbol 12,13-dibutyrate produces negative inotropism and selective antagonism of responses to adrenoceptor agonists in rat atria. Biochem. Pharmacol. 45: 1183-1189.
237. Nosek, T.M., Williams, M.F., Zeigler, S.T., and Godt, R.E. 1986. Inositol trisphosphate enhances calcium release in skinned cardiac and skeletal muscle. Am. J. Physiol. 250: C807-C811.
238. 2-adrenergic receptor. J. Biol. Chem. 264: 7564-7569.
239. 1-Adrenergic inhibition of the β-adrenergically activated Cl-current in guinea pig ventricular myocytes. Circ. Res. 78: 1090-1099.
240. Olson, E.N., and Molkentin, J.D. 1999. Prevention of cardiac hypertrophy by calcineurin inhibition, hope or hype? Circ. Res. 84: 623-632.
241. 1-adrenoceptors in mammalian aortae: subclassification based on chloroethylclonidine, WB 4101 and nifedipine. J. Vasc. Res. 29: 33-40.
242. 2+ transient and contraction in single rat cardiomyocytes. J. Mol. Cell. Cardiol. 24: 809-820.
243. 1-adrenoceptor subtypes in rabbit thoracic aorta. Br. J. Pharmacol. 108: 1071-1076.
244. Osnes, J.B., Aass, H., and Skomedal, T. 1989. Adrenoceptors in myocardial regulation: concomitant contribution from both α-and β-adrenoceptor stimulation to the inotropic response. Basic Res. Cardiol. 84(Suppl. 1): 9-17.
245. Otani, H., Prasad, M.R., Engelman, R.M., Cordis, G.A., and Das, D.K. 1988. Enhanced phosphodiesteratic breakdown and turnover of phosphoinositides during reperfusion of ischemic rat heart. Circ. Res. 63: 930-936.
246. 1-adrenoceptor-mediated inotropic responses in the rat left ventricular papillary muscle. Br. J. Pharmacol. 100: 207-210.
247. 1-adrenoceptor stimulation and phorbol ester in rat isolated left ventricular papillary muscle. Br. J. Pharmacol. 107: 22-26.
248. 1D-adrenergic receptor cDNA. Mol. Pharmacol. 40: 876-883.
249. 1D-adrenergic receptor to multiple signaling pathways is both G protein and cell type specific. Mol. Pharmacol. 44: 784-795.
250. 1A subtype. Mol. Pharmacol. 46: 823-831.
251. 2+ and pH in positive inotropic response of cardiomyocytes to diacylglycerol. Am. J. Physiol. 275: H1473-H1481.
252. Pi, Y., Sreekumar, R., Huang, X., and Walker, J.W. 1997. Positive inotropy mediated by diacylglycerol in rat ventricular myocytes. Circ. Res. 81: 92-100.
253. 1-adrenoceptor. Eur. J. Pharmacol. 199: 279-289.
254. Piascik, M.T., Guarino, R.D., Smith, M.S., Soltis, E.E., Saussy, D.L., and Perez, D.M. 1995. The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. J. Pharmacol. Exp. Ther. 275: 1583-1589.
255. Piascik, M.T., Soltis, E.E., Piascik, M.M., and Macmillan, L.B. 1996. α-Adrenoceptors and vascular regulation: molecular, pharmacologic and clinical correlates. Pharmacol. Ther. 72: 215-241.
256. Post, G.R., and Brown, J.H. 1996. G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J. 10: 741-749.
257. Post, G.R., Goldstein, D., Thuerauf, D.J., Glembotski, C., and Brown, J.H. 1996. Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes. J. Biol. Chem. 271: 8452-8457.
258. 1-adrenergic receptor subtypes in human tissues: implications for human α-adrenergic physiology. Mol. Pharmacol. 45: 171-175.
259. Priori, S.G., and Corr, P.B. 1990. Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Am. J. Physiol. 258: H1796-H1805.
260. Puceat, M., and Vassort, G. 1996. Signalling by protein kinase C isoforms in the heart. Mol. Cell. Biochem. 157: 65-72.
261. Puceat, M., Clement, O., Lechene, P., Pelosin, J.M., Ventura-Clapier, R., and Vassort, G. 1990. Neurohormonal control of calcium sensitivity of myofilaments in rat single heart cells. Circ. Res. 67: 517-524.
262. 1-adrenoceptors mediate positive inotropy via myofibrillar sensitization. Trends Pharmacol. Sci. 13: 263-265.
263. Puceat, M., Hilal-Dandan, R., Strulovici, B., Brunton, L.L., and Brown, J.H. 1994. Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J. Biol. Chem. 269: 16 938-16 944.
264. 1B-adrenergic receptor. J. Biol. Chem. 267: 21 936-21 945.
265. 1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J. Biol. Chem. 272: 14 057-14 061.
266. Rhee, S.G., and Choi, K.D. 1992. Regulation of inositol phospholipid-specific phospholipase C isozymes. J. Biol. Chem. 267: 12 393-12 396.
267. Roach, A.G., Gomeni, R., Mitchard, M., Nicolas, J.P., and Cavero, I. 1978. The blood pressure lowering effects of intravenous versus intracerebroventricular prazosin in anaesthetised cats. Eur. J. Pharmacol. 49: 271-278.
268. Rockman, H.A., Koch, W.J., and Lefkowitz, R.J. 1997. Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. Am. J. Physiol. 272: H1553-H1559.
269. 1D. Biochem. Biophys. Res. Commun. 200: 1177-1184.
270. 1C. J. Biol. Chem. 271: 5839-5843.
271. Rosen, M.R., and Robinson, R.B. 1990. Developmental changes in α-adrenergic modulation of ventricular pacemaker function. Ann. N.Y. Acad. Sci. 588: 137-144.
272. Rosen, M.R., Danilo, P., Robinson, R.B., Shah, A., and Steinberg, S.F. 1988a. Sympathetic neural and α-adrenergic modulation of arrhythmias. Ann. N.Y. Acad. Sci. 533: 200-209.
273. Rosen, M.R., Steinberg, S.F., Chow, Y.K., Bilezikian, J.P., and Danilo, P. 1988b. Role of a pertussis toxin-sensitive protein in the modulation of canine Purkinje fiber automaticity. Circ. Res. 62: 315-323.
274. Ruffolo, R.R. 1985. Distribution and function of peripheral α-adrenoceptors in the cardiovascular system. Pharmacol. Biochem. Behav. 22: 827-833.
275. Rybin, V., and Steinberg, S.F. 1994. Protein kinase C isoform expression and regulation in the developing rat heart. Circ. Res. 74: 299-309.
276. Sadoshima, J., and Izumo, S. 1995. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ. Res. 77: 1040-1052.
277. 1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways. J. Biol. Chem. 271: 31 185-31 190.
278. Saussy, D.L., Goetz, A.S., Queen, K.L., King, H.K., Lutz, M.W., and Rimele, T.J. 1996. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D subtype. J. Pharmacol. Exp. Ther. 278: 136-144.
279. 1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc. Natl. Acad. Sci. U.S.A. 94: 808-813.
280. 1-adrenoceptor mediated effect on inositol phosphate production in the heart. Eur. J. Pharmacol. 134: 377-378.
281. 1-adrenergic and muscarinic receptors in cardiac function. Eur. Heart J. 12(Suppl. F): 83-87.
282. 1-Adrenoceptor-mediated positive inotropic effect and inositol triphosphate increase in mammalian heart. J. Pharmacol. Exp. Ther. 245: 327-335.
283. 1-adrenergic stimulation of inositol phosphates in mammalian heart. Mol. Pharmacol. 42: 134-140.
284. Schumann, H.J., Wagner, J., Knorr, A., Reidemeister, J.C., Sadony, V., and Schramm, G. 1978. Demonstration in human atrial preparations of α-adrenoceptors mediating positive inotropic effects. Naunyn-Schmiedebergs Arch. Pharmacol. 302: 333-336.
285. 1-adrenoceptor subtype: selective antagonists suggest the existence of a fourth subtype. Eur. J. Pharmacol. 227: 433-436.
286. 1-adrenergic receptor subtype. J. Biol. Chem. 265: 8183-8189.
287. Scofield, M.A., Liu, F., Abel, P.W., and Jeffries, W.B. 1995. Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J. Pharmacol. Exp. Ther. 275: 1035-1042.
288. Sei, C.A., Irons, C.E., Sprenkle, A.B., Mcdonough, P.M., Brown, J.H., and Glembotski, C.C. 1991. The α-adrenergic stimulation of atrial natriuretic factor expression in cardiac myocyles requires calcium influx, protein kinase C and calmodulin regulated pathways. J. Biol. Chem. 266: 15 910-15 916.
289. 1-adrenergic receptors. Circ. Res. 67: 1182-1192.
290. + via a pertussis toxin-sensitive pathway. Biophys. J. 54: 219-225.
291. Share, N.N., and Melville, K.I. 1963. Centrally mediated sympathetic cardiovascular responses induced by intraventricular norepinephrine. J. Pharmacol. Exp. Ther. 141: 15-21.
292. Shebuski, R.J., and Zimmerman, B.G. 1985. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs. J. Pharmacol. Exp. Ther. 234: 456-462.
293. Sheridan, D.J. 1986. α-Adrenoceptors and arrhythmias. J. Mol. Cell. Cardiol. 18(Suppl. 5): 59-68.
294. 1-adrenoceptors and native tissues. Mol. Pharmacol. 48: 250-258.
295. Shubeita, H.E., Martinson, E.A., Van Bilsen, M., Chien, K.R., and Brown, J.H. 1992. Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. U.S.A. 89: 1305-1309.
296. 1-adrenergic response. J. Clin. Invest. 72: 732-738.
297. 1adrenergic receptor interaction. Evidence for independent regulation of growth and beating. Circ. Res. 56: 884-894.
298. Simpson, P.C. 1988. Role of proto-oncogenes in myocardial hypertrophy. Am. J. Cardiol. 62: 13G-19G.
299. Simpson, P.C., Kariya, K., Karns, L.R., Long, C.S., and Karliner, J.S. 1991. Adrenergic hormones and control of cardiac myocyte growth. Mol. Cell. Biochem. 104: 35-43.
300. Skomedal, T., Schiander, I.G., and Osnes, J.B. 1988. Both alpha and beta adrenoceptor-mediated components contribute to final inotropic response to norepinephrine in rat heart. J. Pharmacol. Exp. Ther. 247: 1204-1210.
301. Starksen, N.F., Simpson, P.C., Bishopric, N., Coughlin, S.R., Lee, W.M., Escobedo, J.A., and Williams, L.T. 1986. Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proc. Natl. Acad. Sci. U.S.A. 83: 8348-8350.
302. Stehle, R.L., and Ellsworth, H.C. 1937. Dihydroxyphenyl ethanolamine (arterenol) as a possible sympathetic hormone. J. Pharmacol. Exp. Ther. 59: 114-121.
303. 1-receptor. Science (Washington, D.C.), 230: 186-188.
304. Steinberg, S.F., Goldberg, M., and Rybin, V.O. 1995. Protein kinase C isoform diversity in the heart. J. Mol. Cell. Cardiol. 27: 141-153.
305. 1-adrenoceptor densities in different mammalian species. Br. J. Pharmacol. 107: 185-188.
306. 1C-adrenergic receptor from cardiac myocytes. Circ. Res. 75: 796-802.
307. Stiles, G.L. 1996. Multifunctional G proteins. Searching for functions in the heart. Circulation, 94: 602-603.
308. Sugden, P.H. 1999. Signaling in myocardial hypertrophy, life after calcineurin? Circ. Res. 84: 633-646.
309. Sugden, P.H., and Clerk, A. 1998. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76: 725-746.
310. Swynghedauw, B. 1986. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol. Rev. 66: 710-771.
311. 1-adrenoceptors in the rabbit ventricular myocardium. Naunyn-Schmiedebergs Arch. Pharmacol. 343: 669-673.
312. 1 adrenoceptor blocker on cardiac hypertrophy, contractility, and myosin isoenzymes in spontaneously hypertensive rats. Cardiovasc. Res. 25: 565-567.
313. Talosi, L., and Kranias, E.G. 1992. Effect of α-adrenergic stimulation on activation of protein kinase C and phosphorylation of proteins in intact rabbit hearts. Circ. Res. 70: 670-678.
314. Tanaka, H., Manita, S., Matsuda, T., Adachi, M., and Shigenobu, K. 1995a. Sustained negative inotropism mediated by α-adrenoceptors in adult mouse myocardia: developmental conversion from positive response in the neonate. Br. J. Pharmacol. 114: 673-677.
315. Tanaka, H., Matsuda, T., Adachi, M., and Shigenobu, K. 1995b. Effect of sympathectomy on inotropic responsiveness to α-adrenoceptor stimulation in developing mouse myocardia. Can. J. Physiol. Pharmacol. 73: 1285-1288.
316. Terzic, A., and Vogel, S.M. 1990. Amiloride-sensitive actions of an α-adrenoceptor agonist and ouabain in rat atria. J. Mol. Cell. Cardiol. 22: 391-402.
317. Terzic, A., and Vogel, S.M. 1991. On the mechanism of the positive inotropic action of the alpha adrenoceptor agonist, phenylephrine, in isolated rat left atria. J. Pharmacol. Exp. Ther. 257: 520-529.
318. Terzic, A., Anagnostopoulos, T., and Vogel, S.M. 1991. Opposite modulation of ouabain cardiotoxicity by hexamethylene-amiloride and phenylephrine. Naunyn-Schmiedebergs Arch. Pharmacol. 343: 511-518.
319. 1-Adrenergic effects on intracellular pH and calcium and on myofilaments in single rat cardiac cells. J. Physiol. (London), 447: 275-292.
320. 1-adrenoceptors: an overview. Pharmacol. Rev. 45: 147-175.
321. 1d-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta. Life Sci. 57: PL159-163.
322. 2+ and ryanodine. J. Mol. Cell. Cardiol. 19: 841-851.
323. 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol. Pharmacol. 50: 1376-1387.
324. Thorburn, J., and Thorburn, A. 1994. The tyrosine kinase inhibitor, genistein, prevents α-adrenergic-induced cardiac muscle cell hypertrophy by inhibiting activation of the Ras-MAP kinase signaling pathway. Biochem. Biophys. Res. Com. 202: 1586-1591.
325. Thorburn, A., Thorburn, J., Chen, S.Y., Powers, S., Shubeita, H.E., Feramisco, J.R., and Chien, K.R. 1993. HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J. Biol. Chem. 268: 2244-2249.
326. Thorburn, J., Frost, J.A., and Thorburn, A. 1994a. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J. Cell. Biol. 126: 1565-1572.
327. Thorburn, J., Mcmahon, M., and Thorburn, A. 1994b. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. J. Biol. Chem. 269: 30 580-30 586.
328. Thorburn, J., Xu, S., and Thorburn, A. 1997. MAP kinase-and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J. 16: 1888-1900.
329. Tian, W.N., Gupta, S., and Deth, R.C. 1990. Species differences in chloroethylclonidine antagonism at vascular α-1 adrenergic receptors. J. Pharmacol. Exp. Ther. 253: 877-883.
330. 1-Adrenoceptor stimulation enhances the delayed rectifier K+ current of guinea pig ventricular cells through the activation of protein kinase C. Circ. Res. 71: 1441-1446.
331. Tosaki, A., Behjet, N.S., Engelman, D.T., Engelman, R.M., and Das, D.K. 1995. Alpha-1 adrenergic receptor agonist-induced preconditioning in isolated working rat hearts. J. Pharmacol. Exp. Ther. 273: 689-694.
332. 1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes. J. Biol. Chem. 272: 31 915-31 921.
333. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adrenosine by direct activation of protein kinase C. Circ. Res. 75: 576-585.
334. 1-adreoceptors in the cardiac sympathetic nerves of the dog: effects of prazosin and yohimbine on sympathetic neurotransmission to the heart. Eur. J. Pharmacol. 103: 51-56.
335. 1-Adrenoceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ. Res. 70: 1122-1127.
336. 1-adrenergic receptor subtypes in the regulation of arterial pressure. Life Sci. 57: 2291-2308.
337. 1-adrenoceptors in neonatal rabbits. Drug Dev. Res. 24: 251-259.
338. Varma, D.R., Share, N.N., and Melville, K.I. 1962. Cardiovascular responses following injection of picrotoxin into the lateral cerebral ventricle of rabbits. Int. J. Neuropharmacol. 1: 203-206.
339. Vashisht, R., Sian, M., Franks, P.J., and O'Malley, M.K. 1992. Long-term reduction of intimal hyperplasia by the selective alpha-1 adrenergic antagonist doxazosin. Br. J. Surg. 79: 1285-1288.
340. Vaughan-Jones, R.D., Eisner, D.A., and Lederer, J. 1987. Effects of changes in intracellular pH on contractions in sheep cardiac Purkinje fibers. J. Gen. Physiol. 89: 1015-1032.
341. Venema, R.C., Raynor, R.L., Noland, T.A.J., and Kuo, J.F. 1993. Role of protein kinase C in the phosphorylation of cardiac myosin light chain 2. Biochem. J. 294: 401-406.
342. 2+ in permeabilized chick atria. Am. J. Physiol. 258: H1745-H1752.
343. von Euler, U.S. 1951. The nature of adrenergic nerve mediators. Pharmacol. Rev. 3: 247-277.
344. Wagner, J., and Brodde, O.E. 1978. On the presence and distribution of α-adrenoceptors in the heart of various mammalian species. Naunyn-Schmiedebergs Arch. Pharmacol. 302: 239-254.
345. Wagner, J., Endoh, M., and Reinhardt, D. 1974. Stimulation by phenylephrine of adrenergic alpha- and beta-receptors in the isolated perfused rabbit heart. Naunyn-Schmiedebergs Arch. Pharmacol. 282: 307-310.
346. i. J. Mol. Cell. Cardiol. 24: 937-948.
347. 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes. J. Clin. Invest. 85: 1206-1214.
348. 1c. Biochem. Biophys. Res. Commun. 201: 1296-1304.
349. 1-adrenoceptor subtypes to phospholipase C and mitogen activated protein kinase in neonatal rat cardiac myocytes. Eur. J. Pharmacol. 339: 77-86.
350. Wenzel, R., and Su, J.L. 1966. Interactions between sympathomimetic amines and blocking agents on the rat ventricle strip. Arch. Int. Pharmacodyn. 160: 379-389.
351. 1-adrenergic receptor. Circ. Res. 56: 763-766.
352. 1-adrenoceptor blockade with prazosin. J. Cardiovasc. Pharmacol. 10: 96-106.
353. Williams, R.S., and Lefkowitz, R.J. 1979. Thyroid hormone regulation of α-adrenergic receptors: studies in rat myocardium. J. Cardiovasc. Pharmacol. 1: 181-189.
354. + pump current in adult rat ventricular myocytes. Am. J. Physiol. 264: H1315-H1318.
355. Williamson, A.P., Seifen, E., Lindemann, J.P., and Kennedy, R.H. 1994. Effects of WB4101 and chloroethylclonidine on the positive and negative inotropic actions of phenylephrine in rat cardiac muscle. J. Pharmacol. Exp. Ther. 268: 1174-1182.
356. 1A-adrenoceptor stimulation is inhibited by 4-aminopyridine. Eur. J. Pharmacol. 304: 73-80.
357. Woodcock, E.A. 1995. Inositol phosphates in the heart: controversy and consensus. J. Mol. Med. 73: 313-323.
358. Woodcock, E.A., Suss, M.B., and Anderson, K.E. 1995. Inositol phosphate release and metabolism in rat left atria. Circ. Res. 76: 252-260.
359. Woodcock, E.A., Lambert, K.A., Phan, T., and Jacobsen, A.N. 1997. Inositol phosphate metabolism during myocardial ischemia. J. Mol. Cell. Cardiol. 29: 449-460.
360. 1-adrenergic receptors is mediated by the α subunits of Gq family. J. Biol. Chem. 267: 25 798-25 802.
361. 1-adrenergic receptor sequences required for activating different Gα subunits of Gq class of G proteins. J. Biol. Chem. 270: 9828-9832.
362. 1-Adrenoceptor-mediated phosphoinositide breakdown and inotropic responses in diabetic hearts. Am. J. Physiol. 260: H557-H562.
363. 1D-Adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol. Pharmacol. 51: 764-775.
364. 1-adrenergic receptors. Eur. J. Pharmacol. 68: 217-221.
365. Yang, H.T., and Endoh, M. 1994. Dissociation of the positive inotropic effect of methoxamine from the hydrolysis of phosphoinositide in rabbit ventricular myocardium: a comparison with the effects of phenylephrine and the subtype of the alpha-1 adrenoceptor involved. J. Pharmacol. Exp. Ther. 269: 732-742.
366. 1A-adrenoceptor antagonist, inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart. Eur. J. Pharmacol. 312: 281-291.
367. 1D-adrenoceptor protein detectable in rat tissues? Naunyn-Schmiedebergs Arch. Pharmacol. 355: 438-446.
368. 1A-adrenoceptor subtype. Circ. Res. 82: 1078-1085.
369. 1B-adrenoceptors in phenylephrine-induced positive inotropic response in isolated rat left atrium. J. Cardiovasc. Pharmacol. 24: 745-752.
370. Yuan, S.H., Sunahara, F.A., and Sen, A.K. 1987. Tumor-promoting phorbol esters inhibit cardiac functions and induce redistribution of protein kinase C in perfused beating rat heart. Circ. Res. 61: 372-378.
371. Zaza, A., Kline, R.P., and Rosen, M.R. 1990. Effects of α-adrenergic stimulation on intracellular sodium activity and automaticity in canine Purkinje fibers. Circ. Res. 66: 416-426.
372. 2+ channels. Circ. Res. 80: 720-729.
373. 1-adrenoceptor subtypes in hypothyroid rats. Clin. Exp. Pharmacol. Physiol. 24: 481-486.
374. 1-adrenergic receptor subtype-selective antagonist binding. Mol. Pharmacol. 50: 1118-1126.
375. 2+ release from cardiac sarcoplasmic reticulum. Pflugers Arch. Eur. J. Physiol. 418: 1-6.
376. Zhu, H., Garcia, A.V., Ross, R.S., Evans, S.M., and Chien, K.R. 1991. A conserved 28-base-pair element (HF-1) in the rat cardiac myosin light-chain-2 gene confers cardiac-specific and α-adrenergic-inducible expression in cultured neonatal rat myocardial cells. Mol. Cell. Biol. 11: 2273-2281.
377. Zimmer, H.G., Lankat-Buttgereit, B., Kolbeck-Ruhmkorff, C., Nagano, T., and Zierhut, W. 1992. Effects of norepinephrine on the oxidative pentose phosphate pathway in the rat heart. Circ. Res. 71: 451-459.